Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kunal Nepali

Showing results (51-60 of 83) with videos related to

Pageof 9
Sort By:
Medchemcomm|April 2, 2019
Benzoflavone derivatives as potent antihyperuricemic agentsJatinder V Singh, Gurbachan Mal, Gurleen Kaur, et al.
European Journal of Medicinal Chemistry|April 24, 2020
Purine/purine isoster based scaffolds as new derivatives of benzamide class of HDAC inhibitorsKunal Nepali, Ting-Yu Chang, Mei-Jung Lai, et al.
European Journal of Medicinal Chemistry|December 31, 2016
Ring-opened tetrahydro-γ-carbolines display cytotoxicity and selectivity with histone deacetylase isoformsKunal Nepali, Hsueh-Yun Lee, Mei-Jung Lai, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|June 12, 2026
The HDAC Inhibitor RM-3-22 Suppresses Triple-Negative Breast Cancer by Uncoupling Autophagy to Drive FSP1-Dependent FerroptosisEssha Chatterjee, Biswajit Dey, Santanu Basak, et al.
European Journal of Medicinal Chemistry|March 14, 2017
Synthesis, screening and docking of fused pyrano[3,2-d]pyrimidine derivatives as xanthine oxidase inhibitorManroopraj Kaur, Amandeep Kaur, Suhani Mankotia, et al.
European Journal of Medicinal Chemistry|May 22, 2024
Leveraging a rationally designed veliparib-based anilide eliciting anti-leukemic effects for the design of pH-responsive polymer nanoformulationAmandeep Thakur, Yi-Hsuan Chu, N Vijayakameswara Rao, et al.
Bioorganic & Medicinal Chemistry|August 25, 2011
N-(1,3-Diaryl-3-oxopropyl)amides as a new template for xanthine oxidase inhibitorsKunal Nepali, Amit Agarwal, Sameer Sapra, et al.
European Journal of Medicinal Chemistry|March 21, 2021
Pragmatic recruitment of memantine as the capping group for the design of HDAC inhibitors: A preliminary attempt to unravel the enigma of glioblastomaKunal Nepali, Tsung-I Hsu, Chien-Ming Hsieh, et al.
Journal of Medicinal Chemistry|January 6, 2018
(N-Hydroxycarbonylbenylamino)quinolines as Selective Histone Deacetylase 6 Inhibitors Suppress Growth of Multiple Myeloma in Vitro and in VivoHsueh-Yun Lee, Kunal Nepali, Fang-I Huang, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 26, 2025
A novel dual CDC25-HDAC inhibitor suppresses glioblastoma progression via chromosomal passenger complex disruptionRicha Upadhyay, Bidyadhar Sethy, Wen-Bin Yang, et al.
Pageof 9

Showing results (51-60 of 83) with videos related to

Sort By:
Pageof 9
Medchemcomm|April 2, 2019
Benzoflavone derivatives as potent antihyperuricemic agentsJatinder V Singh, Gurbachan Mal, Gurleen Kaur, et al.
European Journal of Medicinal Chemistry|April 24, 2020
Purine/purine isoster based scaffolds as new derivatives of benzamide class of HDAC inhibitorsKunal Nepali, Ting-Yu Chang, Mei-Jung Lai, et al.
European Journal of Medicinal Chemistry|December 31, 2016
Ring-opened tetrahydro-γ-carbolines display cytotoxicity and selectivity with histone deacetylase isoformsKunal Nepali, Hsueh-Yun Lee, Mei-Jung Lai, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|June 12, 2026
The HDAC Inhibitor RM-3-22 Suppresses Triple-Negative Breast Cancer by Uncoupling Autophagy to Drive FSP1-Dependent FerroptosisEssha Chatterjee, Biswajit Dey, Santanu Basak, et al.
European Journal of Medicinal Chemistry|March 14, 2017
Synthesis, screening and docking of fused pyrano[3,2-d]pyrimidine derivatives as xanthine oxidase inhibitorManroopraj Kaur, Amandeep Kaur, Suhani Mankotia, et al.
European Journal of Medicinal Chemistry|May 22, 2024
Leveraging a rationally designed veliparib-based anilide eliciting anti-leukemic effects for the design of pH-responsive polymer nanoformulationAmandeep Thakur, Yi-Hsuan Chu, N Vijayakameswara Rao, et al.
Bioorganic & Medicinal Chemistry|August 25, 2011
N-(1,3-Diaryl-3-oxopropyl)amides as a new template for xanthine oxidase inhibitorsKunal Nepali, Amit Agarwal, Sameer Sapra, et al.
European Journal of Medicinal Chemistry|March 21, 2021
Pragmatic recruitment of memantine as the capping group for the design of HDAC inhibitors: A preliminary attempt to unravel the enigma of glioblastomaKunal Nepali, Tsung-I Hsu, Chien-Ming Hsieh, et al.
Journal of Medicinal Chemistry|January 6, 2018
(N-Hydroxycarbonylbenylamino)quinolines as Selective Histone Deacetylase 6 Inhibitors Suppress Growth of Multiple Myeloma in Vitro and in VivoHsueh-Yun Lee, Kunal Nepali, Fang-I Huang, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 26, 2025
A novel dual CDC25-HDAC inhibitor suppresses glioblastoma progression via chromosomal passenger complex disruptionRicha Upadhyay, Bidyadhar Sethy, Wen-Bin Yang, et al.
Pageof 9